Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Vasohibin: the feedback on a new inhibitor of angiogenesis
Robert S. Kerbel
Robert S. Kerbel
Published October 1, 2004
Citation Information: J Clin Invest. 2004;114(7):884-886. https://doi.org/10.1172/JCI23153.
View: Text | PDF
Commentary Article has an altmetric score of 3

Vasohibin: the feedback on a new inhibitor of angiogenesis

  • Text
  • PDF
Abstract

Angiogenesis is regulated in large part by the balance of various proangiogenic stimulators, such as VEGF, and a diverse group of endogenous inhibitors of angiogenesis, most of which are extrinsic to endothelial cells. With respect to the latter, until recently, none have appeared to be induced as a consequence of a specific, self-regulating, feedback inhibition response. A new inhibitor, called vasohibin, has been uncovered. Vasohibin is selectively induced in endothelial cells by proangiogenic stimulatory growth factors such as VEGF; it appears to operate as an intrinsic and highly specific feedback inhibitor of activated endothelial cells engaged in the process of angiogenesis.

Authors

Robert S. Kerbel

×

Total citations by year

Year: 2025 2023 2020 2019 2018 2017 2016 2015 2014 2013 2012 2010 2009 Total
Citations: 1 1 1 1 1 3 1 2 1 2 1 2 2 19
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (19)

Title and authors Publication Year
Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives
Lee C, Kim MJ, Kumar A, Lee HW, Yang Y, Kim Y
Signal Transduction and Targeted Therapy 2025
Tregs are involved in VEGFA/ VASH1-related angiogenesis pathway in ovarian cancer.
Qiao S, Hou Y, Rong Q, Han B, Liu P
Translational oncology 2023
EB1-dependent long survival of glioblastoma-grafted mice with the oral tubulin-binder BAL101553 is associated with inhibition of tumor angiogenesis.
Bergès R, Tchoghandjian A, Sergé A, Honoré S, Figarella-Branger D, Bachmann F, Lane HA, Braguer D
Oncotarget 2020
N6-methyladenosine induced miR-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1
H Wang, Q Deng, Z Lv, Y Ling, X Hou, Z Chen, X Dinglin, S Ma, D Li, Y Wu, Y Peng, H Huang, L Chen
Molecular Cancer 2019
Association between TAp73, p53 and VASH1 expression in lung adenocarcinoma.
Wu M, Zhang Z, Ma F, Zhang X, Zhang Z, Tang J, Chen P, Zhou C, Wang W
Oncology Letters 2018
MicroRNA‑4530 promotes angiogenesis by targeting VASH1 in breast carcinoma cells
T Zhang, L Jing, H Li, L Ding, D Ai, J Lyu, L Zhong
Oncology Letters 2017
The expression of vasohibin‑1 and its prognostic significance in bladder cancer
B Zhang, Z Wu, W Xie, D Tian, F Chen, C Qin, Z Du, G Tang, Q Gao, X Qiu, C Wu, J Tian, H Hu
Experimental and therapeutic medicine 2017
The roles of vasohibin and its family members: Beyond angiogenesis modulators.
Du H, Zhao J, Hai L, Wu J, Yi H, Shi Y
Cancer biology & therapy 2017
Expression and localization of members of the thrombospondin family during final follicle maturation and corpus luteum formation and function in the bovine ovary
B BERISHA, D SCHAMS, D RODLER, F SINOWATZ, MW PFAFFL
Journal of Reproduction and Development 2016
Vasohibin-1 suppresses colon cancer.
Liu S, Han B, Zhang Q, Dou J, Wang F, Lin W, Sun Y, Peng G
Oncotarget 2015
Advances and challenges in skeletal muscle angiogenesis.
Olfert IM, Baum O, Hellsten Y, Egginton S
American journal of physiology. Heart and circulatory physiology 2015
Angiogenesis in Spontaneous Tumors and Implications for Comparative Tumor Biology
C Benazzi, A Al-Dissi, CH Chau, WD Figg, G Sarli, JT de Oliveira, F Gärtner
The Scientific World JOURNAL 2014
Vasohibin-1 is identified as a master-regulator of endothelial cell apoptosis using gene network analysis
M Affara, D Sanders, H Araki, Y Tamada, BJ Dunmore, S Humphreys, S Imoto, C Savoie, S Miyano, S Kuhara, D Jeffries, C Print, DS Charnock-Jones
BMC Genomics 2013
Vasohibin-1 Expression Is Regulated by Transforming Growth Factor-β/Bone Morphogenic Protein Signaling Pathway Between Tumor-Associated Macrophages and Pancreatic Cancer Cells
Z Shen, H Seppänen, T Kauttu, S Vainionpää, Y Ye, S Wang, H Mustonen, P Puolakkainen
Journal of Interferon & Cytokine Research 2013
Vasohibin-1 and vasohibin-2 expression in gastric cancer cells and TAMs
Z Shen, T Kauttu, H Seppänen, S Vainionpää, Y Ye, S Wang, H Mustonen, P Puolakkainen
Medical Oncology 2012
Recombinant adenovirus encoding vasohibin prevents tumor angiogenesis and inhibits tumor growth
D Li, K Zhou, S Wang, Z Shi, Z Yang
Cancer Science 2010
Vasohibin-1 as a potential predictor of aggressive behavior of ductal carcinoma in situ of the breast
K Tamaki, H Sasano, Y Maruo, Y Takahashi, M Miyashita, T Moriya, Y Sato, H Hirakawa, N Tamaki, M Watanabe, T Ishida, N Ohuchi
Cancer Science 2010
Vasohibin inhibits angiogenic sprouting in vitro and supports vascular maturation processes in vivo
J Kern, M Steurer, G Gastl, E Gunsilius, G Untergasser
BMC Cancer 2009
Vasohibin-1 in human breast carcinoma: A potential negative feedback regulator of angiogenesis
K Tamaki, T Moriya, Y Sato, T Ishida, Y Maruo, K Yoshinaga, N Ohuchi, H Sasano
Cancer Science 2009

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 8 patents
30 readers on Mendeley
See more details